NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Polku Therapeutics

Polku Therapeutics

Private
HelsinkiHealthcare & Life Scienceshttps://www.polkutx.com/

Last Round

Grant

Jan 31, 2025

Total Funding Raised

$2.56M

Company Overview

Polku Therapeutics is a biotechnology company that develops first-in-class small-molecule therapies targeting the PREP–PP2A pathway to treat neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, and frontotemporal dementia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryCNS disorderssmall molecule therapeuticspreclinical researchcentral nervous systemCNSbiotech startuptherapeutic pipelinedrug developmentneurological disorderspsychiatric disordersbiotech licensingdrug candidatepreclinical pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Polku Therapeutics Comparables

Compare Polku Therapeutics with similar companies based on industry and business-model similarity.

Polku Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Polku Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 31, 2025
Pre SeedSep 17, 2024

Polku Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 31, 2025

    $330K from Rainwater Charitable Foundation and Alzheimer's Association.

  • Sep 17, 2024

    $2.34M round led by Torrey Pines Investment and Innovestor.

Polku Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Polku Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Polku Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Employee Range5
Year Founded2024
Last FundingJan 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.